| REVIEW ARTICLE |
|
| Year : 2021 | Volume
: 39
| Issue : 4 | Page : 169-174 |
|
|
Taiwan dermatological association recommendations for coronavirus disease of 2019 vaccination in patients treated with immunotherapeutics
Chih-Hung Lee1, Yu-Huei Huang2, Chia-Yu Chu3
1 Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung; Department of Dermatology, Chang Gung University College of Medicine, Taoyuan, Taiwan
2 Department of Dermatology, Chang Gung University College of Medicine, Taoyuan; Department of Dermatology, Taipei Chang Gung Memorial Hospital, Taipei, Taiwan
3 Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
Correspondence Address:
Dr. Chia-Yu Chu
Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei 10002
Taiwan
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/ds.ds_50_21
|
|
|
This article aims to present current COVID-19 vaccination considerations for patients on immunotherapeutics for the management of immune-mediated dermatological diseases and summarize the recommendations relevant to clinical practice in Taiwan. These Taiwan Dermatological Association (TDA) recommendations are intended to be dynamic in nature and serve as an interim guide to optimize patient care at this current juncture. It is expected that our clinical practice would continually evolve and be informed by new evidence that emerges in this pandemic.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
